4502:TYO
Takeda Pharmaceutical Co Ltd
5 643,00 JP¥
arrow_downward
-1,54%(-88,00) 1D
2 tet, 3:30:00 m.d., GMT+9 · JPY
search
Të gjitha simbolet
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për 4502...
Hap
5 652 JP¥
I lartë
5 685 JP¥
I ulët
5 616 JP¥
Kapitalizimi i tregut
9,04 bln
Vëllimi mesatar
4,25 mln
Vëllimi
4,22 mln
Dividendi
3,54%
Dividendi tremujor
50 JP¥
Data e ndërprerjes së dividendit
29 sht 2026
Maksimumi 52-javor
6 033 JP¥
Minimumi 52-javor
4 102 JP¥
Fitimet për aksion
-103 JP¥
Aksionet në qarkullim
784,48 mln
Numri i punonjësve
47 mijë
Hap
5 652 JP¥
I lartë
5 685 JP¥
I ulët
5 616 JP¥
Kapitalizimi i tregut
9,04 bln
Vëllimi mesatar
4,25 mln
Vëllimi
4,22 mln
Dividendi
3,54%
Dividendi tremujor
50 JP¥
Data e ndërprerjes së dividendit
29 sht 2026
Maksimumi 52-javor
6 033 JP¥
Minimumi 52-javor
4 102 JP¥
Fitimet për aksion
-103 JP¥
Aksionet në qarkullim
784,48 mln
Numri i punonjësve
47 mijë
Lajmet
Nga burimet në ueb dhe partnerët e lajmeve
GlobeNewswire
·
28 minuta më parë
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance
·
24 minuta më parë
Peter Brandt Calls XRP a “Fool Coin” Just Before 473 Million XRP Lists on Nasdaq. Does Payment Utility Count for Anything in the Price?
The Daily News | Texas' Oldest Newspaper
·
20 minuta më parë
Traders work on the floor of the NYSE in New York
Seeking Alpha
·
57 minuta më parë
SPYM ETF: S&P 500 Monthly Dashboard For October
Profili
The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company. It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue. The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States. As of 2015, Christophe Weber was appointed as the CEO and president of Takeda. In 2026, Julie Kim was noted in a news item as "CEO-elect". Wikipedia
Rreth Takeda Pharmaceutical Co Ltd
Drejtori ekzekutivChristophe Weber | Christophe Weber
Punonjësit47 mijë
Themeluar më12 qer 1781
Selia-
Sektori-
Uebsajtitakeda.com